Kimberly-Clark Corporation (NASDAQ:KMB) is included among the 14 High Yield Dividend Stocks with Sustainable Payouts. BofA Cuts Kimberly-Clark (KMB) Target on Lower Multiple Applied to 2027 Earnings On January 28, BofA analyst Anna Lizzul lowered her price objective on Kimberly-Clark Corporation (NASDAQ:KMB) to $130 from $148 and kept a Buy rating on the stock. The firm said Kimberly-Clark continues to execute on its transformation plan. The lower target reflects a reduced P/E multiple applied to the com ...

Joining us now, George Heel. He's the vice president of commodity research at George, great to have you with us. >> Thanks for having me.>> You know, it's funny that we we had this list of fundamental reasons why the metals would decline today and yet the move has been sort of memeish, which is by definition not pinned by fundamental drivers. So, what did you make of the of the drop today. Of course.Well, I think you know silver has obviously had a outsized move against gold over the last few months and thi ...

American Healthcare REIT, Inc. (NYSE:AHR) is one of the High-Flying Stocks to Buy Right Now. On January 20, Truist analyst Michael Lewis reduced its price objective on the company’s stock to $52 from $53, while keeping a “Buy” rating, as reported by The Fly. Notably, the firm made adjustments in the ratings and targets across the broader real estate investment trust group in relation to the 2026 outlook. Truist Reduces PT on American Healthcare REIT (AHR) Stock Furthermore, the firm is “Neutral” on REITs ...

AtaiBeckley Inc. (NASDAQ:ATAI) is one of the best fast growing penny stocks to buy according to analysts. On January 20, Guggenheim initiated coverage of AtaiBeckley with a Buy rating and an $11 price target, identifying the firm as a differentiated leader in the field of next-generation psychiatry. The firm noted that the recent merger with Beckley Psytech provides full ownership of the lead asset, BPL-003, which has shown compelling efficacy and durability in Phase IIIb trials for treatment-resistant d ...

Gogo Inc. (NASDAQ:GOGO) is one of the best fast growing penny stocks to buy according to analysts. On January 16, Morgan Stanley reduced its price target for Gogo to $8 from $15 with an Equal Weight rating, reflecting expectations of a low-growth 2026 due to various product transitions. The firm’s adjusted valuation incorporates updated model assumptions and highlights an ongoing industry debate regarding the development of Direct-to-Device technology within the Space Technology services sector. In other ...

Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX) is one of the best fast growing penny stocks to buy according to analysts. On January 14, Citi analyst Yigal Nochomovitz increased the price target for Lexicon to $2.10 from $1.90 while maintaining a Buy rating. This upward revision resulted from an updated financial model that accounted for upcoming milestones under the LX9851 partnership with Novo Nordisk. In Q3 2025, Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX) reported revenue of $14.2 million, which was drive ...

AGNC Investment Corp. (NASDAQ:AGNC) ranks among the most undervalued REIT stocks to buy right now. Piper Sandler raised its price target for AGNC Investment Corp. (NASDAQ:AGNC) to $11 from $11 on January 15, while keeping an Overweight rating on the company’s stock. The boost reflects narrowing agency MBS spreads, which Piper Sandler believes will benefit AGNC’s forward tangible book values. Moreover, earlier in January, AGNC Investment Corp. (NASDAQ:AGNC) announced a number of financial and structural u ...

Immunocore Holdings plc (NASDAQ:IMCR) is one of the Best Small Cap Stocks Ready to Explode in 2026. On January 21, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on the stock with a $100 price target. Earlier, on January 6, UBS also initiated Immunocore Holdings plc (NASDAQ:IMCR) with a Buy rating and a $55 price target. ​Analysts at UBS see significant potential upside for the stock because it is currently trading close to the value of its approved drug Kimmtrak. The firm noted that this ...

Core Viewpoint - Micron Technology, Inc. (NASDAQ:MU) has seen a significant increase in its stock price, attributed to its capability in manufacturing advanced memory chips and ongoing demand driven by data centers [2][3]. Group 1: Stock Performance - Micron Technology's shares have risen by 387% over the year [2]. - Bernstein analysts raised the price target for Micron from $270 to $330 while maintaining an Outperform rating [2]. - HSBC increased Micron's price target from $350 to $500, citing strong pricing power and a Buy rating [2]. Group 2: Market Dynamics - The company is positioned to benefit from strong memory chip prices through 2026 due to robust demand from data centers [2]. - Jim Cramer highlighted that Micron is experiencing a shortage, which is affecting its ability to meet demand rather than a lack of demand itself [3]. Group 3: Investment Perspective - While Micron is viewed as a potential investment, there is a belief that some AI stocks may offer higher returns with limited downside risk [3].

We recently published Jim Cramer Discussed These 10 Stocks & Commented On Gold Price.  Sandisk Corporation (NASDAQ:SNDK) is one of the stocks Jim Cramer discussed. Computer memory storage manufacturer Sandisk Corporation (NASDAQ:SNDK)’s shares are among the top performers on the market as they are up by triple-digit percentage since early 2025. In 2026, several analysts have discussed the firm. One recent coverage came from Mizuho, as it increased Sandisk Corporation (NASDAQ:SNDK)’s share price target to ...